medical covid 19 neutralizing antibody test diagnostic kit sale at thailand market

Just fill in the form below, click submit, you will get the price list, and we will contact you within one working day. Please also feel free to contact us via email or phone. (* is required).

  • SARS-CoV-2 specific antibody responses in COVID-19

    2021-6-29 · We are especially excited to begin our expansion into COVID-19 neutralizing antibody testing that receives nearly double the reimbursement vs. traditional COVID antibody testing (~79 vs. ~42). We believe neutralizing antibody testing will become more critical to help determine robust COVID-19 …

    Get Price
  • SARS-CoV-2 Rapid Antigen Test - Diagnostics

    The SARS-CoV-2 Rapid Antigen Test is a reliable, rapid chromatopgraphic immunoassay for the qualitative detection of specific antigens of SARS-CoV-2 present in the human nasopharynx. This test is an aid in detecting antigen from the SARS-CoV-2 virus in individuals suspected of COVID-19. This product is strictly intended for professional use in ...

    Get Price
  • Test Kits to Detect SARS-CoV-2 - rapidmicrobiology

    The majority of molecular-based detection kits made available for SARS-CoV-2 are real-time reverse transcriptase PCR assays. In some of the kits that were released in the early days of the outbreak, mismatching with SARS-CoV was a problem. But as time went on and more countries became involved, more companies began developing highly specific ...

    Get Price
  • Immunoassay Market Size & Share Report, 2021-2028

    The global immunoassay market size was valued at USD 21.4 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.7% from 2021 to 2028. This growth can be attributed to the increase in chronic and infectious diseases, including the outbreak of COVID-19. In addition, the rise in the geriatric population, which is ...

    Get Price
  • Elecsys® Anti-SARS-CoV-2 - Diagnostics

    Elecsys ® Anti-SARS-CoV-2 is an immunoassay for the in vitro qualitative detection of antibodies (including IgG) to SARS-CoV-2 in human serum and plasma. The assay uses a recombinant protein representing the nucleocapsid (N) antigen in a double-antigen sandwich assay format, which favors detection of high affinity antibodies against SARS-CoV-2.

    Get Price
  • GenScript Biotech, Ph biotech firm to distribute COVID-19 ...

    It is the first 'rapid' test kit that can detect neutralizing antibodies (NAbs). NAbs refer to a specific type of antibody that has been shown to interfere with virus re-infection and maybe a good indicator of potential immunity against COVID-19. NAbs have been shown to be indicative of immunity in other viral infections.

    Get Price
  • EDI™ Novel Coronavirus COVID-19 ELISA Kits

    2020-4-13 · Information for US Customers. At this time, the KT-1032 EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit, KT-1033 EDI™ Novel Coronavirus COVID-19 IgM ELISA Kit, and the KT-1034 EDI™ COVID-19 Nucleocapsid IgG Quantitative ELISA Kit are available for research use only in the United States.updated 12/4/2020. It is important to note the following: This test has not been reviewed by the …

    Get Price
  • COVID-19 Antibody Test Released by Ortho Clinical

    2020-4-3 · COVID-19 Antibody Test Released by Ortho Clinical Diagnostics Raritan, NJ Aligned with its mission to improve and save lives with diagnostics, Ortho Clinical Diagnostics today announced it is launching to market its SARS-CoV-2 (COVID-19/coronavirus) antibody test—the VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack.

    Get Price
  • Covid19 : COVID-19 - Quest Diagnostics

    2021-8-3 · Quest Diagnostics begins to perform COVID-19 antibody testing. In addition to molecular diagnostic laboratory testing, Quest now provides COVID-19 antibody testing using blood samples. Antibodies developed by the body in response to a viral infection may provide potential immunity against future infection. *.

    Get Price
  • Roche - Roche launches new quantitative antibody test to ...

    2020-9-18 · The test is the latest addition to the comprehensive Roche diagnostic portfolio to help healthcare systems combat COVID-19 through testing in the laboratory and at the point of care. Currently, this portfolio includes molecular, serology and digital solutions which help diagnose and manage COVID-19 during the initial stages of infection, during ...

    Get Price
Learn More Information About Our Products Know More